These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18635663)

  • 41. The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression.
    Rossi F; Bellini G; Luongo L; Mancusi S; Torella M; Tortora C; Manzo I; Guida F; Nobili B; de Novellis V; Maione S
    Pharmacol Res; 2013 Feb; 68(1):7-15. PubMed ID: 23142558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positive regulation of osteogenesis by bile acid through FXR.
    Cho SW; An JH; Park H; Yang JY; Choi HJ; Kim SW; Park YJ; Kim SY; Yim M; Baek WY; Kim JE; Shin CS
    J Bone Miner Res; 2013 Oct; 28(10):2109-21. PubMed ID: 23609136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain.
    Yamamoto W; Mikami T; Iwamura H
    Eur J Pharmacol; 2008 Mar; 583(1):56-61. PubMed ID: 18279850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation.
    Zaiss MM; Sarter K; Hess A; Engelke K; Böhm C; Nimmerjahn F; Voll R; Schett G; David JP
    Arthritis Rheum; 2010 Aug; 62(8):2328-38. PubMed ID: 20506516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-osteopontin monoclonal antibody prevents ovariectomy-induced osteoporosis in mice by promotion of osteoclast apoptosis.
    Zhang B; Dai J; Wang H; Wei H; Zhao J; Guo Y; Fan K
    Biochem Biophys Res Commun; 2014 Sep; 452(3):795-800. PubMed ID: 25201732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency.
    Smoum R; Baraghithy S; Chourasia M; Breuer A; Mussai N; Attar-Namdar M; Kogan NM; Raphael B; Bolognini D; Cascio MG; Marini P; Pertwee RG; Shurki A; Mechoulam R; Bab I
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8774-9. PubMed ID: 26124120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss.
    Kim TH; Jung JW; Ha BG; Hong JM; Park EK; Kim HJ; Kim SY
    J Nutr Biochem; 2011 Jan; 22(1):8-15. PubMed ID: 20233653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of osteoclast differentiation and function by phosphate: potential role of osteoclasts in the skeletal abnormalities in hypophosphatemic conditions.
    Hayashibara T; Hiraga T; Sugita A; Wang L; Hata K; Ooshima T; Yoneda T
    J Bone Miner Res; 2007 Nov; 22(11):1743-51. PubMed ID: 17638577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
    Thomas A; Baillie GL; Phillips AM; Razdan RK; Ross RA; Pertwee RG
    Br J Pharmacol; 2007 Mar; 150(5):613-23. PubMed ID: 17245363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.
    Tambaro S; Casu MA; Mastinu A; Lazzari P
    Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.
    Baldassano S; Serio R; Mule' F
    Eur J Pharmacol; 2008 Mar; 582(1-3):132-8. PubMed ID: 18234188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential roles of MAPK kinases MKK3 and MKK6 in osteoclastogenesis and bone loss.
    Boyle DL; Hammaker D; Edgar M; Zaiss MM; Teufel S; David JP; Schett G; Firestein GS
    PLoS One; 2014; 9(1):e84818. PubMed ID: 24400116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects.
    Hu SJ; Cheng G; Zhou H; Zhang Q; Zhang QL; Wang Y; Shen Y; Lian CX; Ma XQ; Zhang QY; Qin LP
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy.
    Szczesniak AM; Porter RF; Toguri JT; Borowska-Fielding J; Gebremeskel S; Siwakoti A; Johnston B; Lehmann C; Kelly ME
    Neuropharmacology; 2017 Feb; 113(Pt B):627-638. PubMed ID: 27569993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026).
    Armour KJ; van 't Hof RJ; Armour KE; Torbergsen AC; Del Soldato P; Ralston SH
    Arthritis Rheum; 2001 Sep; 44(9):2185-92. PubMed ID: 11592384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of cannabinoid type 2 receptor by JWH133 protects heart against ischemia/reperfusion-induced apoptosis.
    Li Q; Wang F; Zhang YM; Zhou JJ; Zhang Y
    Cell Physiol Biochem; 2013; 31(4-5):693-702. PubMed ID: 23711495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dysregulation of 5-hydroxytryptamine 6 receptor accelerates maturation of bone-resorbing osteoclasts and induces bone loss.
    Park KR; Kim EC; Hong JT; Yun HM
    Theranostics; 2018; 8(11):3087-3098. PubMed ID: 29896304
    [No Abstract]   [Full Text] [Related]  

  • 60. Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice.
    Kara FM; Doty SB; Boskey A; Goldring S; Zaidi M; Fredholm BB; Cronstein BN
    Arthritis Rheum; 2010 Feb; 62(2):534-41. PubMed ID: 20112380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.